Is outsourcing ideal for early phase clinical studies?
Is the best solution to outsource early phase clinical studies?
This is the question asked by the Head of Clinical Pharmacology Unit at Roche, Dr C.Kirkpatrick.
He said it would be a mistake to assume that outsourcing is the ideal solution for every company and its requirements.
"Global drug development spending is expected to top $105bn (€82bn) by 2010 with 40 per cent of this business expected to be dished out in outsourcing contracts.
CROs' reputation has been earned solely on the back of the quality of work they do. In explaining the advantages of outsourcing a whole program, Kirkpatrick spoke of, “off-loading all the hassle, making full use of the partner's expertise.”
“It also works well if you have a trusted partner in whom you have confidence,” he added."
To view the full article click here
This is the question asked by the Head of Clinical Pharmacology Unit at Roche, Dr C.Kirkpatrick.
He said it would be a mistake to assume that outsourcing is the ideal solution for every company and its requirements.
"Global drug development spending is expected to top $105bn (€82bn) by 2010 with 40 per cent of this business expected to be dished out in outsourcing contracts.
CROs' reputation has been earned solely on the back of the quality of work they do. In explaining the advantages of outsourcing a whole program, Kirkpatrick spoke of, “off-loading all the hassle, making full use of the partner's expertise.”
“It also works well if you have a trusted partner in whom you have confidence,” he added."
To view the full article click here
0 Comments:
Post a Comment
<< Home